There is a lot of frustration on the board today.
Post# of 36566
(Total Views: 284)
Posted On: 09/23/2020 2:13:42 PM
There is a lot of frustration on the board today.
I don't know if Joe reads the board from time to time or just waits to pop in and then let's us know he is here.
But, as shareholders the PPS does affect us. We make money or we lose money. Depending on the amount of shares, it can be a lot either way and depending on what you bought the shares at, the loss could be substantial.
This is all common sense.
So, seeing the PPS down to .20 is frustrating. For the old timers, you all have seen it at far less. But then again, you have had expectations for a long time of seeing it go back up.
For us newbies (last couple of years), we bought shares anywhere in the range of .20's now to 2.00 something.
We have listened to CCs, we have seen PRs. We have seen deals, we have seen funding.
We have had expectations come and go. Generex to be listed, then on hold. NGIO to be listed, moved, listed, moved, now hopefully listed in October?
We have been through a lot and we will go through a lot more. Hopefully a lot more that is good.
I don't understand this .20 PPS. Honestly, I don't understand the lack of news on the Peptides. But that's me.
But as a still shareholder right now whose wife whacks him on the back of the head from time to time for buying this stock, I still believe after everything, that Generex / NGIO can still pull this out. The technology they have, products, just the overall setup, they can succeed.
We get frustrated, I know I do and you will see me question on here. But I still believe this company has a lot to offer overall and hopefully we will see it soon enough.
So, Joe if you are reading...... It's time to pull this all out and show that Generex / NGIO can and will succeed.
I don't know if Joe reads the board from time to time or just waits to pop in and then let's us know he is here.
But, as shareholders the PPS does affect us. We make money or we lose money. Depending on the amount of shares, it can be a lot either way and depending on what you bought the shares at, the loss could be substantial.
This is all common sense.
So, seeing the PPS down to .20 is frustrating. For the old timers, you all have seen it at far less. But then again, you have had expectations for a long time of seeing it go back up.
For us newbies (last couple of years), we bought shares anywhere in the range of .20's now to 2.00 something.
We have listened to CCs, we have seen PRs. We have seen deals, we have seen funding.
We have had expectations come and go. Generex to be listed, then on hold. NGIO to be listed, moved, listed, moved, now hopefully listed in October?
We have been through a lot and we will go through a lot more. Hopefully a lot more that is good.
I don't understand this .20 PPS. Honestly, I don't understand the lack of news on the Peptides. But that's me.
But as a still shareholder right now whose wife whacks him on the back of the head from time to time for buying this stock, I still believe after everything, that Generex / NGIO can still pull this out. The technology they have, products, just the overall setup, they can succeed.
We get frustrated, I know I do and you will see me question on here. But I still believe this company has a lot to offer overall and hopefully we will see it soon enough.
So, Joe if you are reading...... It's time to pull this all out and show that Generex / NGIO can and will succeed.
(5)
(0)